Luewan Suchaya, Sirichotiyakul Supatra, Charoenkwan Pimlak, Phirom Krittaya, Tongsong Theera
Department of Obstetrics and Gynecology, Chiang Mai University, Chiang Mai, Thailand.
Thalassemia and Hematology Center, Chiang Mai, Thailand.
Fetal Diagn Ther. 2022;49(11-12):528-535. doi: 10.1159/000528510. Epub 2022 Dec 27.
Hemoglobin H-Pakse (Hb H-PS) disease is a variant of non-deletional Hb H disease associated with various degrees of anemia. The disorder is rare but commonly seen in Southeast Asia. However, the prenatal course of Hb H-PS disease has never been published. The objective of this report was to describe prenatal diagnosis and management of Hb H-PS disease, which is theoretically much more critical in fetal life than adult life.
The prenatal courses of two fetuses affected by Hb H-PS were comprehensively explored. Both of them showed sonographic signs of fetal anemia at 19-20 weeks of gestation (increased cardiac size and increase middle cerebral artery peak systolic velocity [MCA-PSV]). On follow-up scans, both revealed frank hydropic signs at 22-24 weeks. One fetus died at 24 weeks, shortly before the scheduled intrauterine blood transfusion (IUT). The other one underwent IUT at 22 weeks, leading to completely reversed hydropic signs, which resulted in successful outcomes that ended with the delivery of a healthy baby at term. The fetus needed only one IUT, and the course of anemic status improved in late pregnancy. IUT in this case was possibly beneficial to adult life.
Fetuses with Hb H-PS may be associated with hydrops fetalis, usually occurring at mid-pregnancy. The hydrops tends to improve in late gestation. If they can pass through this most critical period in utero without anemic insults in developing organs, good long-term prognosis can be expected. This successful prenatal diagnosis and intrauterine treatment may encourage care providers to pay more attention to fetal Hb H-PS disease, to prevent anemic hypoxia in developing organs and adult diseases of fetal origin.
血红蛋白H-帕塞(Hb H-PS)病是一种与不同程度贫血相关的非缺失型Hb H病变体。这种疾病较为罕见,但在东南亚地区较为常见。然而,Hb H-PS病的产前病程从未被报道过。本报告的目的是描述Hb H-PS病的产前诊断和管理,该病在胎儿期理论上比成人期更为关键。
对两名受Hb H-PS影响的胎儿的产前病程进行了全面探究。他们在妊娠19 - 20周时均表现出胎儿贫血的超声迹象(心脏增大和大脑中动脉收缩期峰值流速[MCA-PSV]增加)。在后续扫描中,两者在22 - 24周时均出现明显的水肿迹象。一名胎儿在24周时死亡,就在预定的宫内输血(IUT)前不久。另一名胎儿在22周时接受了IUT,水肿迹象完全逆转,最终成功分娩出一名足月健康婴儿。该胎儿仅需一次IUT,贫血状态在妊娠后期有所改善。本病例中的IUT可能对成人期有益。
患有Hb H-PS的胎儿可能与胎儿水肿有关,通常发生在妊娠中期。水肿在妊娠后期往往会改善。如果他们能够在子宫内度过这个最关键的时期,而发育中的器官没有受到贫血的损害,有望获得良好的长期预后。这种成功的产前诊断和宫内治疗可能会促使医护人员更加关注胎儿Hb H-PS病,以预防发育中器官的贫血缺氧和胎儿源性成人疾病。